EPRX
Eupraxia Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · CA
$8.40
+12.00%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.39x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.04x
- Net debt / EBITDA
- 1.01x
Liquidity & coverage
- Current ratio
- 16.00x
- Quick ratio
- 16.00x
- Cash ratio
- 15.63x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $128.0M
Cash & dividend
- FCF / debt
- -19.89x
- Cash flow / debt
- -19.50x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026